NsGene

Neurotech

This biotechnology company develops encapsulated cell therapy implants to treat chronic retinal diseases for patients with macular telangiectasia and other eye conditions.

Neurogene Inc

This company develops genetic medicines and gene therapies to treat patients and families affected by rare neurological diseases including Rett syndrome and Batten disease.

Neuroplast

This company develops autologous stem cell therapies to treat patients with neurodegenerative diseases including spinal cord injuries and amyotrophic lateral sclerosis.

Neurona Therapeutics

This company develops off-the-shelf regenerative neural cell therapies for patients with drug-resistant epilepsy and other chronic disorders of the central nervous system.

Neuro

Mangrove Neuro develops cell and tissue replacement therapies, specifically cortical grafts, for patients suffering from neurodegeneration and brain trauma.

BE Therapeutics

This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.

GenSight Biologics

This company develops gene therapies for patients suffering from neurodegenerative retinal diseases and central nervous system disorders.

Lysogene

Lysogene develops gene therapies to treat rare central nervous system diseases in paediatric patients.